On Oct 28, major Wall Street analysts update their ratings for $NOV Inc (NOV.US)$, with price targets ranging from $21 to $25.
Morgan Stanley analyst Daniel Kutz maintains with a buy rating, and adjusts the target price from $23 to $21.
Evercore analyst James West maintains with a buy rating, and adjusts the target price from $27 to $25.
TD Cowen analyst Marc Bianchi maintains with a buy rating, and adjusts the target price from $28 to $22.
Stifel analyst Stephen Gengaro maintains with a buy rating, and adjusts the target price from $25 to $24.
RBC Capital analyst Keith Mackey maintains with a hold rating, and maintains the target price at $21.
Furthermore, according to the comprehensive report, the opinions of $NOV Inc (NOV.US)$'s main analysts recently are as follows:
The expectation is that the ongoing cycle will continue to benefit NOV Inc., with the company's emphasis on enhancing its supply chain and profitability profile predicted to increase cash flows, leading to a more rapid distribution of cash to shareholders.
NOV Inc.'s Q3 adjusted EBITDA surpassed expectations, and robust free cash flow is anticipated to back the company's substantial capital return plan. This plan is marked by a significant dividend increase, an extensive share repurchase program, and the addition of a supplementary dividend, which collectively aim to distribute an annual total equating to 50% of the company's free cash flow to its shareholders.
The firm expressed that NOV Inc.'s fourth-quarter guidance was more disappointing than anticipated due to a product mix that is impacting margins negatively. Furthermore, the outlook for a subdued first half of the year was suggested by indications that offshore drilling clients might reduce expenditures in light of impending contract intervals.
Here are the latest investment ratings and price targets for $NOV Inc (NOV.US)$ from 7 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美东时间10月28日，多家华尔街大行更新了$华高 (NOV.US)$的评级，目标价介于21美元至25美元。
摩根士丹利分析师Daniel Kutz维持买入评级，并将目标价从23美元下调至21美元。
Evercore分析师James West维持买入评级，并将目标价从27美元下调至25美元。
TD Cowen分析师Marc Bianchi维持买入评级，并将目标价从28美元下调至22美元。
斯迪富分析师Stephen Gengaro维持买入评级，并将目标价从25美元下调至24美元。
加皇资本市场分析师Keith Mackey维持持有评级，维持目标价21美元。
此外，综合报道，$华高 (NOV.US)$近期主要分析师观点如下：
预计持续周期将继续使华高受益，公司强调增强供应链和盈利能力概况的重点预计将增加现金流，导致更快将现金分配给股东。
华高第三季度调整后的EBITDA超出预期，并预期强劲的自由现金流将支持公司的大规模资本回报计划。该计划标志着显著增加股息、广泛的股份回购计划，并增加补充股息，总体目标是将公司自由现金流的年度总额的50%分配给股东。
公司表示，由于产品组合对利润率产生负面影响，华高第四季度的业绩指引比预期更令人失望。此外，基于海上钻井客户可能减少支出的迹象，暗示年初将更为沉闷的前景，这是由于即将到来的合同间隔期。
以下为今日7位分析师对$华高 (NOV.US)$的最新投资评级及目标价：
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
